Application of CLEC-2 (C-Type Lectin Receptor-2) in preparing medicine for treating craniocerebral injury
A kind of craniocerebral injury and drug technology, applied in the field of biomedicine, can solve the problem that the effect of craniocerebral injury is not reported, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Twenty-four 6-week-old ICR mice with basically the same body weight were randomly divided into four groups, 6 in each group, namely: simple control group (Sham group), simple craniocerebral injury group (TBI group), craniocerebral injury pretreatment group (Pre group) and craniocerebral injury post-treatment group (Post group).
[0064] The modeling steps of craniocerebral injury are as follows: the mice in each group were fixed with a stereotaxic instrument, the mouse scalp was cut to expose the skull, and the coronal suture and sagittal suture were divided into two sides, and a 4mm diameter hole was drilled in the left hemisphere. A small circular hole exposes the brain tissue, and then hits it with a free-fall striker to establish a craniocerebral injury model. The mice in the Sham group did not perform any operations before and after craniocerebral injury, and the mice in the Pre group were given 400 ng of platelet CLEC-2 by intracerebroventricular injection 30 minu...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


